MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Phase 1

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2008-01-28

Last Posted Date: 2011-05-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 76

Registration Number: NCT00602706

A Simple Clinical Tool to Help Assess Patient Volume (Fluid) Status

Completed

Conditions: Sepsis

First Posted Date: 2008-01-24

Last Posted Date: 2008-01-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 84

Registration Number: NCT00599794

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States

Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation

Not Applicable

Completed

Conditions: Breast Cancer

First Posted Date: 2008-01-11

Last Posted Date: 2014-07-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 89

Registration Number: NCT00591864

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Confocal Laser Microscopy in Non Erosive Reflux Disease

Completed

Conditions: Acid Reflux Disease
Heartburn

Interventions: Device: Cell~vizio (Laser connfocal microscopy)

First Posted Date: 2008-01-09

Last Posted Date: 2013-05-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT00588939

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study

Phase 3

Terminated

Conditions: Atrial Fibrillation
Heart Failure

Interventions: Drug: FDA approved rate and rhythm control drugs
Device: AV Node ablation and device implant

First Posted Date: 2008-01-09

Last Posted Date: 2013-04-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 27

Registration Number: NCT00589303

Locations: 🇨🇦
University of Calgary and Calgary Health Region, Calgary, Alberta, Canada
🇺🇸
Chattanooga Heart Institute, Chattanooga, Tennessee, United States
🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

and more 3 locations

Fat Gain and Cardiovascular Disease Mechanisms

Phase 3

Completed

Conditions: Sleep Apnea Syndromes
Hypertension
Obesity

Interventions: Dietary Supplement: 1000 extra calories

First Posted Date: 2008-01-09

Last Posted Date: 2013-11-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 69

Registration Number: NCT00589498

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

A Prospective, Randomized, Controlled Study Comparing Three Tibial Component Designs in Total Knee Arthoplasty

Not Applicable

Completed

Conditions: Total Knee Arthroplasty

Interventions: Device: The Zimmer NexGen Legacy Knee System, modular cemented tibia
Device: The Zimmer NexGen Legacy Knee System, non-modular cemented tibia.
Device: The Zimmer NexGen Legacy Knee System, non-modular uncemented tibia

First Posted Date: 2008-01-09

Last Posted Date: 2012-05-28

Lead Sponsor: Mayo Clinic

Target Recruit Count: 397

Registration Number: NCT00589147

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Comparison of A Mobile-Bearing Total Knee System With A Fixed-Bearing Total Knee System In Cemented Total Knee Arthroplasty

Not Applicable

Completed

Conditions: Degenerative Joint Disease

Interventions: Device: Sigma Knee System
Device: Sigma Pressfit Condylar Posterior Cruciate Substituting System with a metal back tibial tray
Device: Sigma Pressfit Condylar Posterior Cruciate Substituting System all polyethylene tray

First Posted Date: 2008-01-09

Last Posted Date: 2013-01-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 240

Registration Number: NCT00589108

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

Phase 2

Terminated

Conditions: Precancerous Condition

Interventions: Biological: Rituximab

First Posted Date: 2008-01-09

Last Posted Date: 2014-05-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 21

Registration Number: NCT00588822

Locations: 🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

Primary Hyperoxaluria Mutation Genotyping

Completed

Conditions: Primary Hyperoxaluria

Interventions: Genetic: Genetic Analysis

First Posted Date: 2008-01-09

Last Posted Date: 2016-07-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 902

Registration Number: NCT00589225

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy